Pathology Articles | Today's Clinical Lab

The Covaris truCOVER WGS PCR-free Library Prep Kit enhances the efficiency and quality of library preparation for whole genome sequencing of multiple sample types.

Emerging Technologies Guide: April 2025

Today's Clinical Lab

Recent new and emerging technologies in the field of laboratory medicine from the 2025 April Cancer & Precision Medicine issue of Today's Clinical Lab

A clinical laboratory professional wearing a white lab coat and blue gloves loads CSF brain cancer samples for analysis.

Belay Diagnostics Partners with GenomOncology to Support High-Performance Liquid Biopsy Test for Central Nervous System Cancer Detection

GenomOncology

The customized solution enables the team to make informed variant interpretations and treatment recommendations

With the pathologists in short supply, new approaches to intraoperative frozen section consultations include whole slide imaging options

Improving Intraoperative Frozen Section Consultations Through the Use of Whole Slide Imaging

Mika Kuisma

Digital slides can address problems that result in wasted time, caseload back-up, and diagnostic delays

Clinical labs are poised to use computational pathology to support routine reporting and increase the efficiency of workflows, such as for cancer detection.

Computational Pathology Will Offset Clinical Lab Staffing Shortages by Streamlining Workflows

Rob Monroe, MD, PhD

AI and clinical data can also help laboratories maximize the potential of precision medicine

Faster Results, Fewer Bottlenecks: Optimizing Pathology Workflows

Agilent Technologies

Reduce turnaround time, enhance diagnostic accuracy, and minimize manual labor in immunohistochemistry

Amplified Sciences—led by CEO Diana Caldwell (right) and chief scientific officer V. Jo Davisson—has received regulatory clearance under the federal Clinical Laboratory Improvement Amendments program to test PanCystPro, which risk stratifies patients with pancreatic cystic lesions, a precursor for pancreatic cancer. The company was featured in the Indiana Economic Development Corp.’s 2024 edition of Entrepreneurship Indiana.

Amplified Sciences Earns CLIA Certification for Its First Test to Assess Pancreatic Cancer Risk

Purdue University

Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial in 2025

With BD selling its diagnostics and life sciences business, clinical labs may see a new player could emerge in the IVD market.

What BD Selling Its Diagnostics Business Could Mean for Clinical Labs

Scott Wallask, BA

Becton Dickinson’s plans will shift the IVD market and possibly create a stronger contender

Photo of a clinical laboratory professional pointing to a digital pathology slide. Digital pathology adoption challenges continue for clinical labs, according to Labcorp.

Slow Digital Pathology Adoption Continues, According to Labcorp Report

Scott Wallask, BA

Chief Medical Officer Deborah Sesok-Pizzini discusses digital pathology challenges and opportunities

Illustration of colorful DNA helices representing genetic testing against a yellow background.

New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making

National Comprehensive Cancer Network

New resource from the National Comprehensive Cancer Network outlines how and why to access genetic counseling and testing for multiple hereditary cancers

Close up photo of a list of antibodies tested for in a patient medical report.

People Find Medical Test Results Hard to Understand, Increasing Overall Worry

Michigan Medicine - University of Michigan

The problem is that many medical reports aren’t written with patients in mind

Photo of the hand of a clinical lab professional wearing a blue glove and holding a cancer histology slide stained for biomarkers among a background of other slides.

ASH 2024: Dozens of Presentations Advance Multiple Myeloma Research

University of Miami Miller School of Medicine

C. Ola Landgren and colleagues discuss adapting to a field transformed by new immunotherapy drugs and targeted therapies and how to best combine treatments

Photo of a clinical laboratory worker’s gloved hand picking up a blood tube sample to test for lymphoma.

ASH 2024: Antibody Shows Encouraging Results for Treating High-Risk Follicular Lymphoma and Marginal Zone Lymphoma

University of Miami Miller School of Medicine

Two clinical trials testing loncastuximab tesirine in patients with high-risk follicular lymphoma or with rare, marginal zone lymphoma show encouraging results